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Abstract
Pancreatic cancer remains a significant and unresolved 
therapeutic challenge. Currently, the only curative 
treatment for pancreatic cancer is surgical resection. 
Pancreatic surgery represents a technically demand-
ing major abdominal procedure that can occasionally 
lead to a number of pathophysiological alterations re-
sulting in increased morbidity and mortality. Systemic, 
rather than surgical complications, cause the majority 
of deaths. Because patients are increasingly referred to 
surgery with at advanced ages and because pancreatic 
surgery is extremely complex, anaesthesiologists and 
surgeons play a crucial role in preoperative evaluations 
and diagnoses for surgical intervention. The anaesthe-
tist plays a key role in perioperative management and 
can significantly influence patient outcome. To optimise 
overall care, patients should be appropriately referred 
to tertiary centres, where multidisciplinary teams (sur-
gical, medical, radiation oncologists, gastroenterolo-
gists, interventional radiologists and anaesthetists) 
work together and where close cooperation between 
surgeons and anaesthesiologists promotes the safe 
performance of major gastrointestinal surgeries with 
acceptable morbidity and mortality rates. In this review, 
we sought to provide simple daily recommendations to 
the clinicians who manage pancreatic surgery patients 
to make their work easier and suggest a joint approach 
between surgeons and anaesthesiologists in daily deci-
sion making.
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: Currently, the only curative treatment for pan-
creatic cancer is surgical resection. However, this type 
of surgery is still burdened by considerable morbidity 
due to its complexity and to the type of referred pa-
tients (elderly and with many co-morbidities). We be-
lieve that anaesthetic management with proper surgical 
approaches can play a key role in the outcome of the 
patient. Simple perioperative precautions in anaesthetic 
management (patient risk assessment, fluids manage-
ment, prevention of surgical site infection, thrombo-
prophylaxis, intraoperative ventilation, and intensive 
postoperative management) can help to ensure that 
these surgical operations are performed with reason-
able assurance.
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cancer-related death in the United States and the sixth in 
Europe, with the lowest survival rate for any solid cancer 
worldwide[1]. It is the most lethal type of  digestive cancer 
and exhibits a five year survival rate of  5% with a range 
that is correlated with staging and location. The main 
reason for this extremely poor prognosis is that less than 
15% of  patients are diagnosed with resectable tumours[2]. 
Currently, the only curative treatment for PC is surgical re-
section, although even for resectable tumours, cure is still 
rare (5-year survival rate of  approximately 15%-20%)[3].
Pancreatic surgery represents a challenging and tech-
nically demanding major abdominal procedure that occa-
sionally results in a number of  pathophysiological altera-
tions during the early postoperative period that account 
for increased rates of  morbidity and mortality.
Systemic, rather than surgical complications, cause 
the majority of  PC-related deaths[4]. More than 80% of  
PCs are diagnosed in patients older than 65 years. Many 
PC patients are or have been heavy smokers[5,6], and 
nearly 80% of  PC patients have either frank diabetes or 
impaired glucose tolerance[7]; venous thromboembolism 
remains a major complication of  PC[8]. For these reasons, 
PC patients who undergo a major abdominal surgery are 
at increased anaesthesiological risk. In the light of  these 
issues, it is important to refer these patients to centres 
with a high volume of  operations where a multidisci-
plinary approach is applied to improve the overall out-
come. Moreover, careful patient selection is fundamental.
In this setting, the anaesthesiologist plays a crucial 
role during preoperative evaluation, which together with 
a proper surgical approach and a concerted effort with 
medical physicians, radiation oncologists, gastroenter-
ologists and interventional radiologists is crucial for a 
favourable perioperative outcome[9]. Patient outcome can 
be significantly influenced by anaesthesiological manage-
ment (Table 1), starting with patient stratification and 
selection, continuing throughout the surgical operation 
and finishing with postoperative care [intensive care unit 
(ICU), recommendations for the ward][10].
PREOPERATIVE MANAGEMENT
Informed patient consent
Despite recent developments in operative technique and 
postoperative care, pancreatic surgery remains associated 
with high morbidity and mortality. Postoperative compli-
cations such as primarily pancreatic fistula, haemorrhage, 
abscess, and delayed gastric emptying still occur at a fre-
quency of  30% to 60%, resulting in a mortality rate of  1% 
to 5%[11]. For this reason and due to the lethality of  the 
pancreatic cancer despite surgical treatment, the patient 
should be informed about the therapeutic procedure and 
any potential complications or disabilities to facilitate a 
conscious involvement in the decision-making process.
In the case of  patients of  advanced age who require 
pancreatic surgery, formal mental status testing can help 
determine whether a patient can be considered capable 
of  making this type of  decision.
Dementia is an extreme predictor of  poor outcome, 
exhibiting surgical mortality rates that are increased by 
52%[12]. The decision to classify an elderly patient eligible 
for surgery cannot exclude preoperative mental status.
Preoperative risk assessment
A complete history, physical, laboratory examinations, 
and an assessment of  the surgical risks should be includ-
ed in the preoperative evaluation of  an elective surgery.
Currently, the definition of  preoperative risk remains 
vague and difficult to standardise, as it is influenced by 
many variables attributed to patient- and surgery-specific 
variability[13]. Recently, a variety of  scoring systems has 
been developed, and the Physiologic and Operative Se-
verity Score for the Enumeration of  Mortality and mor-
bidity (POSSUM) model by Copeland et al[14] was recog-
nised as the most effective for general surgery[15]. This 
model, which uses scores relating to 12 physiological and 
6 operative variables, was developed to postoperatively 
predict 30-d mortality and morbidity. The application of  
the predictive POSSUM and P-POSSUM (Portsmouth 
modification of  POSSUM)[16] models to cases of  pancre-
atic surgery has generated conflicting results. The imple-
mentation of  this scoring system in the routine practice has 
proven to be difficult, and a recent review by Wang et al[17] 
has found POSSUM to overpredict postoperative mortal-
ity. Despite these limitations, there is still a role for POS-
SUM as a useful tool in pancreatic surgery. Individual 
POSSUM scores should not preclude pancreatic resec-
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  Preoperative Intraoperative Postoperative
  Informed patient consent Combined general and epidural analgesia Early nasogastric tube, catheter and drain 
removal
  Preoperative risk assessment Prevention of surgical site infection:
Antimicrobial prophylaxis
Avoid hypothermia
Glucose control
Early oral nutrition/glycaemic control/goal-
directed fluid therapy
Pain relief/non-opioid oral analgesia
  Evaluation and optimisation of preoperative physical   
  conditions and medications
Blood transfusion management Intensive postoperative ambulation and 
prevention of venous thromboembolism
  Nutritional status Intraoperative fluid management Intensive respiratory rehabilitation
  Risk stratification, rationale for thromboprophylaxis, and   
  recommendations
Optimisation of intraoperative ventilation
Intraoperative thromboprophylaxis
Intensive postoperative management
Table 1  A schematic representation of the integrated management of perioperative patients undergoing surgery for pancreatic cancer
Modified from Grade et al[10].
tion in clinical practice but might help surgeons modify 
expectations of  postoperative outcomes[18].
Due to the limitations of  the POSSUM model, more 
trials are needed to adequately evaluate this scoring sys-
tem in predicting postoperative mortality for pancreatic 
surgery.
Evaluation and optimisation of preoperative physical 
conditions and medications
A growing number of  old patients benefits from a surgi-
cal procedure[19]. Age is an independent risk factor of  
postoperative mortality and postoperative complications 
and can cause a gradual progressive loss in the biological 
reserves for maintaining physiological homeostasis un-
der stress. In addition, an increasing number of  patients 
present with one or more age-related chronic conditions, 
which further decrease their ability to respond to stress. 
Cardiac and pulmonary diseases are the most frequently 
observed co-morbidities that anaesthetists and surgeons 
must manage during this complex surgery.
A complete history of  prior medical and surgical 
conditions and a full medication list are particularly 
important[20,21].
Cardiovascular risk evaluation: Cardiovascular com-
plications are among the most common and significant 
postoperative problems in elderly patients. A practical 
guideline for perioperative cardiovascular evaluation for 
non-cardiac surgery has been proposed by the American 
College of  Cardiology and American Heart Association 
Task Force[22]. Patients should be assessed using an ap-
proach that considers clinical predictors, the risk of  the 
proposed operation and the functional capacity.
Ageing is accompanied by increased vascular and ven-
tricular stiffness, diastolic dysfunction and an increased 
risk of  heart failure[23]. Diastolic dysfunction even with 
a normal or supranormal ejection fraction might elicit 
a significant effect on the perioperative outcome and 
management of  elderly patients[12]. Diastolic dysfunction 
might significantly affect perioperative haemodynamics, 
response to fluid shifts, anaesthetic drugs and other peri-
operative medications.
Patients with cardiovascular diseases are sensitive to 
haemodynamic instability and often require increased 
filling pressures to generate an adequate cardiac output. 
The anaesthetist must carefully manage fluids during the 
operation to avoid overload or rapid volume administra-
tion. Moreover, the anaesthetist must maintain a normal 
haemoglobin value (Nair et al[24] demonstrated that anae-
mia was strongly associated with diastolic dysfunction in 
patients with coronary artery disease) and, if  possible, 
must choose volatile anaesthetics that appear to improve 
diastolic parameters (in contrast to propofol, which elicits 
the opposite effect) as measured by echocardiography[25]. 
Thoracic epidural analgesia should be strongly suggested, 
not only for pain management and for decreasing respi-
ratory complications but also because its use appears to 
improve cardiac function by improving the diastolic char-
acteristics of  the left ventricle[26,27].
Prophylactic perioperative β-blockade: In general, car-
diovascular medication should not be discontinued prior 
to surgery. In the perioperative setting, β-blockers are not 
contraindicated in patients with diastolic heart failure and 
should be continued in patients with systolic heart failure. 
However, caution is warranted with the acute adminis-
tration of  β-blockers in situations of  decompensating 
systolic heart failure. Nonetheless, given the risk of  acute 
withdrawal, β-blockade in patients with coronary artery 
diseases or coronary artery disease risk factors should not 
be discontinued preoperatively. Rather, perioperatively 
increasing the dosage of  the patient’s β-blockade regimen 
would most likely be beneficial[28-30].
If  a patient who is scheduled for elective pancreatic 
surgery requires a new prescription, it should be started 
at least 1 mo prior to the procedure to allow for dose ad-
justment[31,32].
Pulmonary risk evaluation: Pulmonary complications 
such as pneumonia, failure to wean, and postextubation 
respiratory failure represent the second most frequent 
types of  postoperative complication following wound 
infection, with an estimated incidence rate ranging from 
2.0% to 5.6% following surgery[33,34]. Pulmonary disease 
increases the risk of  postoperative complications, ac-
counting for 40% of  postoperative complications and 
20% of  deaths[35]. Age-related changes, such as increased 
closing volumes and decreased expiratory flow rates can 
predispose older patients to pulmonary complications.
Some postoperative pulmonary complication (PPC) 
predictors after pancreatic surgery are summarised in 
Table 2 (modified from Canet et al[36]).
Identifying the patients who are at high risk for PPCs, 
can help the anaesthetist to design individually tailored 
management approaches[37-39]. Pharmacologic measures 
for managing these complications are either unavailable 
or limited, and as a result, treatments must be based on 
physical therapy and respiratory support ventilation.
Finally, the ability to predict PPCs would enable cli-
nicians to give patients more precise risk assessments, 
thereby facilitating their decision making.
Nutritional status and mechanical bowel preparation
The prevalence of  malnutrition is high in patients who 
are submitted for surgery and ranges from 35% to almost 
60%[40]. Malnutrition has been consistently associated 
with impaired immunity[41] and can lead to increased 
complications, such as pressure ulcers, delayed wound 
healing, increased risk of  infections, impaired muscular 
and respiratory functions[42], as well as increased mortality 
and poor clinical outcomes.
Nutritional status should be determined because nu-
tritional deficiencies are common in patients who have 
undergone pancreatic resection for malignant tumours. 
Because malnutrition is potentially reversible with ap-
propriate nutritional support, the early identification of  
high-risk patients is crucial, and preoperative malnutrition 
screening is required to identify and to treat the malnutri-
tion[43]. Recently, the routine screening of  patients to iden-
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from clinical practice in pancreatic surgery. A recent 
review examined and compared the application of  FT 
protocols with standard care in elective liver and pancre-
atic surgeries, showing that FT programmes can enhance 
post-operative recovery and reduce the length of  hospital 
stays with no increase in adverse events, such as re-admis-
sions, morbidity or mortality[53,54]. The avoidance of  MBP, 
together with other measures including the application 
of  epidural analgesia, the prevention of  intra-operative 
hypothermia, fluid restriction, post-operative nutritional 
care and early mobilisation, collectively represent essential 
elements of  a FT programme that is warranted for com-
plex surgical operations such as pancreatic resection[55,56]. 
In our experience FT programmes for hepatopancreatic 
resections appear to be safe and associated with a reduc-
tion in the length of  hospital stays.
Risk stratification, rationale for thromboprophylaxis, 
and recommendations
In patients undergoing general and abdominal-pelvic 
surgery, the risk of  venous thromboembolism (VTE) 
varies depending on both patient- and procedure-specific 
factors[57]. Pancreatic cancer is among the most common 
malignancies associated with thrombosis, as it occurs in 
50% of  total patients[58]. Prophylaxis against postopera-
tive venous thromboembolism should be tailored to the 
patient’s level of  risk. A model (the Caprini score) that 
can potentially be used for such purposes estimates VTE 
risk by adding points for various VTE risk factors[59].
Pharmacological prophylaxis reduces the risk of  pul-
monary embolism by 75% in general surgical patients and 
by 57% in medical patients[60]. The use of  low-molecular-
weight heparins (LMWHs) to prevent thrombotic events in 
these patients is a common and well-documented practice.
Current recommendations strongly advise effective 
and preventive strategies for all hospitalised patients who 
are defined as moderate to high risk for VTE and are 
awaiting pancreatic surgery.
LMWHs appear to be effective and are potentially 
associated with a lower risk of  bleeding when the first 
dose is administered 12 h preoperatively[57,61]. We recom-
mend the administration of  LMWH from the day prior 
to surgery to all patients scheduled for pancreatic cancer 
surgery.
In the case of  patients who are receiving anticoagu-
lants or antiplatelet therapy and require an elective sur-
gery or procedure, the actual guidelines addressing their 
management are underlined in Table 3 and are modified 
from Douketis et al[62].
INTRAOPERATIVE MANAGEMENT
Combined general and epidural anaesthesia
The use of  thoracic epidurals is widespread for intraop-
erative and postoperative analgesia. Thoracic epidural 
anaesthesia (TEA) reduces sympathetic activity, thereby 
influencing the perioperative function of  vital organ sys-
tems. Thoracic epidural anaesthesia has been used widely 
to provide excellent pain relief, to attenuate the catabolic 
tify risk of  malnutrition has been recommended by many 
national, international, and specialist organisations[44,45]. 
The malnutrition universal screening tool (MUST) for 
adults was recently validated by several studies, which 
have demonstrated that as a screening procedure, MUST 
is rapid and easy to use[46,47].
The MUST appears to be a valid and easy screening 
tool for pancreatic surgery[20], which can identify patients 
at high risk for major complications and death. Further-
more, the MUST can prompt the implementation of  ef-
fective nutritional interventions to reduce poor outcomes 
and thereby optimise the use of  postoperative critical 
care beds and hospital resources.
As soon as malnutrition is recognised, preoperative 
nutritional supplements should be provided when possi-
ble. This supplementation can include high-energy foods, 
vitamins, enteral feedings, or, if  necessary, total parenteral 
nutrition.
Mechanical bowel preparation
“Enhanced recovery” or “fast-track” (FT) programmes, 
which were first developed by Kehlet[48], are structured 
interdisciplinary strategies that have been introduced 
to optimise peri-operative care and to accelerate post-
operative recovery[49]. A major intervention principle of  
this approach is the avoidance of  preoperative mechani-
cal bowel preparation (MBP), which has been employed 
as a preventative measure in gastrointestinal surgery for 
more than a century as an essential factor for avoiding 
infectious complications and anastomotic dehiscence. FT 
programmes, which exclude MBP, have been proposed 
more often in other surgical fields (elective colorectal, 
gastro-oesophageal and aortic surgery) and rarely have 
been applied to liver and pancreatic surgery[50]. The appli-
cation of  MBP in this type of  surgery has been evaluated 
by limited studies (a retrospective case-control study by 
the Jefferson University[51] and a review by Salvia et al[52]), 
which have shown that it did not improve perioperative 
outcomes. At our institution, MBP has been excluded 
  Patient-related factors Surgery-related factors Preoperative testing-
related factors
  Congestive heart failure Abdominal surgery Serum albumin 
concentration 
< 2.5 g/dL
  ASA score > 2 Surgery duration > 3 h Anaemia 
(Hb < 10 g/dL)
  Age > 65 yr General anaesthesia Low SpO2
  Chronic obstructive 
  pulmonary disease
Transfusions Chest X ray
  Functional dependence Prolonged hospitalisation
  Weight loss
  Impaired sensorium
  Cigarette smoking
  Respiratory infections   
  within the past month
Table 2  Perioperative clinical predictors of postoperative 
pulmonary complication in pancreatic oncological surgery
Modified from Canet et al[36]. ASA: American Society of Anesthesiologists.
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response to abdominal surgery, to lower the incidence of  
pulmonary morbidity, to decrease the cardiac metabolic 
demand, to reduce the risk of  thromboembolic compli-
cations, to promote the recovery of  intestinal function 
and to minimise motor blockade[63,64]. Moreover, epidural 
anaesthesia and mild hypercapnia have been shown to 
increase subcutaneous tissue oxygenation[65].
The combination of  general anaesthesia and thoracic 
epidural anaesthesia has become the technique of  choice 
at many institutions for major abdominal surgery[66,67].
Recent studies have suggested that for some types of  
cancer, TEA might also reduce the rate of  recurrence af-
ter surgical resection. The possibility of  reducing tumour 
recurrence makes the combination of  general anaesthesia 
and TEA even more appealing, despite the existence of  
certain contraindications[68,69].
TEA represents a powerful tool that is available to 
anaesthesiologists for perioperative intervention in pan-
creatic surgery. At our University Medical Centre, we 
strongly address its use in the context of  multimodal 
intervention.
Prevention of surgical site infection 
Surgical site infections continue to represent a substantial 
source of  morbidity and mortality in the surgical patient 
population. They are the second most common cause of  
nosocomial infection after urinary tract infections and 
account for approximately 17% of  all hospital-acquired 
infections[70].
Increasing evidence indicates that anaesthesiologists 
play a prominent role in the prevention of  surgical site 
infections. Anaesthesiologists are involved in the adminis-
tration of  antibiotics, in the use of  supplemental oxygen, 
in the maintenance of  normothermia and normoglycae-
mia, in the perioperative fluid management and in the 
administration of  blood transfusions[71,72]. Therefore, 
decreasing surgical site infections depends on the optimi-
sation of  some perioperative conditions, which are gener-
ally controlled by anaesthesiologists.
Antimicrobial prophylaxis
The anaesthesiologist can play a simple but effective 
role in the prevention of  surgical site infections by en-
suring the administration of  appropriate antimicrobial 
prophylaxis[73,74].
Current recommendations state that the infusion of  
the first dose of  drug should begin within 30-60 min of  
incision. This period can be lengthened to 120 min for 
drugs such as vancomycin, where high infusion rates 
have been associated with complications[75]. The drugs 
used should be defined in advance for each interven-
tion, including alternatives in the event that the patient 
presents with any contraindication for the frontline anti-
biotics. The determination of  the ideal preoperative an-
tibiotic therapy for a patient who is awaiting pancreatic 
surgery requires efforts by a multidisciplinary team (an-
aesthesiologist, surgeon and microbiologist). A proper 
and effective antimicrobial prophylaxis should be based 
upon the application of  a standard protocol and quality 
management[76].
Concerning the duration and dosage of  prophylaxis, 
the guidelines generally recommended a single standard 
intravenous therapeutic dose of  antibiotic in the majority 
of  procedures. Repeated doses have only been indicated 
in special circumstances such as prolonged surgery with a 
duration longer than the half-life of  the antibiotic used or 
cases of  major blood loss. This recommendation is based 
on published evidence, which suggested that the admin-
istration of  short-duration prophylaxis is equally effective 
as longer-duration prophylaxis in the prevention of  surgi-
cal site infections[77,78]. It is advisable to administer at least 
two antibiotic doses during pancreatic surgery.
Avoid hypothermia
Mild perioperative hypothermia (core body temperature 
34-36 ℃) is commonly observed in surgical patients. The 
complications of  mild perioperative hypothermia have 
been studied extensively and include increased duration 
of  hospitalisation, increased intraoperative blood loss 
and transfusion requirements, increased adverse cardiac 
events, and an increase in patient thermal discomfort in 
the recovery room[79,80]. The effects of  mild hypothermia 
on surgical site infections have also been studied. The 
major relation between hypothermia and increased surgi-
  In patients receiving bridging anticoagulation with a therapeutic-dose Ⅳ of unfractionated heparin, treatment is recommended to be stopped no later 
  than at 4 to 6 h prior to surgery
  In patients receiving bridging anticoagulation with a therapeutic-dose of LMWH, the last preoperative dose of LMWH is recommended to be 
  administered at approximately 24 h prior to surgery instead of at 12 h prior to surgery
  In patients receiving bridging anticoagulation with a therapeutic-dose of LMWH and are undergoing high-bleeding-risk surgery, resumption of the   
  therapeutic dose of LMWH is recommended at 48 to 72 h after surgery instead of within 24 h following surgery
  In moderate-to-high-risk patients receiving acetylsalicylic acid who require non-cardiac surgery, treatment with acetylsalicylic acid is recommended to be 
  continued around the time of surgery instead of discontinued at 7 to 10 d prior to surgery
  In patients with a coronary stent who require surgery, deferment of surgery is recommended at 6 wk or 6 mo after the placement of a bare-metal or drug-
  eluting stent, respectively, instead of initiating surgery during these time periods
  In patients requiring surgery within 6 wk or 6 mo of the placement of a bare-metal or drug-eluting stent, respectively, continuing perioperative 
  antiplatelet therapy is recommended instead of stopping therapy at 7 to 10 d prior to surgery
Table 3  Guidelines on the prophylaxis of venous thromboembolism and antiplatelet and anticoagulant management adjusted 
according to recent guidelines 
Modified from Douketis et al[62]. LMWHs: Low-molecular-weight heparins.
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cal site infections is thought to be a decrease in subcuta-
neous tissue perfusion mediated by vasoconstriction[81,82]. 
The reduced oxygenation of  the wound is responsible 
for reduced oxidative killing elicited by neutrophils and 
for the reduced production of  superoxide radicals for any 
given oxygen tension[80].
Intraoperative core temperature monitoring (oe-
sophageal temperature probe) and adequate control of  
body temperature are essential during pancreatic cancer 
surgery[83]. Heat loss during the first hour of  anaesthesia 
is generally a result of  the redistribution of  core-to-pe-
ripheral temperature gradients caused by an anaesthetic-
induced decrease in vasoconstriction. The exposure of  
the large bowel, significant amounts of  fluids adminis-
tered, and long surgical procedures represent other causes 
of  intraoperative hypothermia. Actively pre-warming 
patients for 2 h prior to the induction of  either general or 
regional anaesthesia[80] using forced-air warming blankets 
together with fluid-warming systems represents an im-
portant way to keep patients normothermic[84].
Glucose control
Hyperglycaemia is associated with an increased risk of  
morbidity and mortality[85]. Several studies have shown 
the negative effects of  hyperglycaemic phases during 
hospitalisation on the rate of  nosocomial infections, 
length of  hospital stay and mortality[71,86]. In a recent trial, 
the use of  insulin infusions to maintain serum glucose at 
less than 110 mg/dL in critically ill patients decreased the 
mortality rate from 8.0% to 4.6%, regardless of  diabetic 
status[87]. In subsequent studies, the concept of  intensive 
glucose control was modified towards less-extreme blood 
glucose levels because of  dangerous hypoglycaemic epi-
sodes that were attributable for worse patients outcomes 
than that originally reported[88,89]. Intraoperative glucose 
control should be a standard practice during long and 
complex surgical procedures to reduce perioperative 
complications. 
The optimal glucose level during the periopera-
tive period has not been prospectively investigated, and 
the available data from recent reports do not indicate a 
specific threshold for the treatment of  hyperglycaemia. 
There is some evidence that keeping glucose levels within 
a range of  110-180 mg/dL and not limiting the treatment 
to values higher than 200 mg/dL is safe and appropriate.
It is important not only to limit glucose control dur-
ing the intraoperative period but also to continue insulin 
infusion during the postoperative period. The frequent 
and precise measurement of  glycaemia must become a 
standard of  pancreatic cancer patient management both 
during surgical procedures as well as during the postop-
erative period[90].
Blood transfusion management
Several published studies have demonstrated how blood 
product transfusions increase the postoperative risk of  
infection[91,92]. 
Published guidelines generally concur that although 
transfusions are not beneficial when the haemoglobin 
concentrations are greater than 100 g/L, they confer 
benefit when the haemoglobin concentrations are less 
than 60-70 g/L. Studies that have described transfusion 
management in Jehovah’s witnesses have shown that 
morbidity and mortality only increase postoperatively for 
each gram of  decrement when the haemoglobin concen-
tration is less than 70 g/L[93]. Patients with cardiovascular 
diseases exhibit a significantly increased rate of  post-
operative mortality, and for this reason, the transfusion 
trigger should be different for patients with or without 
cardiovascular disease[94,95]. Although multiple trials have 
assessed the effects of  transfusion thresholds on pa-
tient outcome, the literature is insufficient for defining 
a transfusion trigger in surgical patients with substantial 
blood loss. In the light of  recent findings, the transfu-
sion management of  surgical patients should be patient 
specific and should not be based on arbitrary laboratory 
values but guided by patient covariables[96-99]. As under-
lined by the recent guidelines on perioperative bleeding 
management of  the European Society of  Anaesthesiolo-
gy, we suggest a target haemoglobin concentration of  7-9 
g/dL and the guidance of  transfusions based on levels 
of  serum lactate, base deficit, and central venous oxygen 
saturation[100].
Intraoperative fluid management
Optimal perioperative fluid management remains highly 
challenging, particularly in patients undergoing major ab-
dominal surgery[101-103]. Perioperative physicians generally 
administer intravenous fluids to replace fasting deficits, 
third space losses, and blood loss to maintain adequate 
cardiac output, blood pressure, and urine output.
Fluid excess can have a negative impact on cardiac, 
pulmonary, bowel function and wound healing, predis-
posing the patient to tissue oedema and anastomotic 
breakdown[104,105]. In contrast, excessive fluid restriction 
can expose the patient to hypovolaemia and hypoperfu-
sion[106]. Surgery causes inflammation and a correspond-
ing release of  mediators that can induce local tissue oede-
ma[107]. Anaesthetists generally manage perioperative fluid 
administration by using unmonitored fixed fluid regimens 
and estimating fluid loss.
In recent years, restrictive fluid management has re-
placed this approach, and the concept of  fast-track sur-
gery has challenged the traditional administration of  large 
amounts of  fluids during surgery[108,109].
These findings have prompted fervent discussion on 
how liberal or restrictive perioperative fluid management 
should be applied, and several randomised controlled trial 
have attempted to settle this issue[104,108,110,111].
Due to the lack of  consensus on the optimal imple-
mentation of  fluid management, a new and more precise 
approach based on goal-directed fluid therapy and indi-
vidualised fluid administration has been developed[103]. 
Goal-directed fluid optimisation has markedly increased 
tissue oxygen tension and microcirculatory perfusion in 
both healthy and perianastomotic tissues compared to 
the restricted fluid strategy[106,112,113].
Central venous pressure (CVP) remains the most 
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widely used clinical marker of  volume status, despite nu-
merous studies indicating no association between CVP 
and circulating blood volume[114]. Because of  this limi-
tation, central venous and pulmonary artery occlusion 
pressures, which are the only variables for guided fluid 
therapy and optimised preload, are not recommended. 
Dynamic parameters such as stroke volume variation 
or pulse pressure variation provide a more favourable 
prediction of  fluid responsiveness. Individualised goal-
directed fluid therapy, particularly oesophageal Doppler-
guided fluid optimisation, has been shown to improve 
patient outcomes and to reduce the length of  hospital 
stays compared with conventional fluid replacement[115]. 
Doppler-guided fluid boluses appear to improve clinical 
outcomes, particularly in elderly and frail patients[116,117]. 
This method, however, cannot be universally performed 
for practical and financial reasons[118].
Using a “goal-directed” approach, it is generally pos-
sible to replace lost plasma, whereas the extracellular 
compartment cannot currently be monitored. Therefore, 
losses from the latter should be replaced based on the 
protocol suggested by Chappell et al[101], which involves 
the substitution of  insensible perspiration with 1 mL/kg 
per hour during abdominal surgery and does not include 
the possibility of  primary fluid consumption by the third 
space, the existence of  which is denied[119].
The optimal solution for volume replacement and 
optimisation remains an ongoing issue of  heated debate. 
The goal of  perioperative fluid management is to main-
tain fluid balance and to minimise the possible risks by 
choosing the right fluid at the right time. 
Colloids are criticised because of  their ability to dif-
fuse into the interstitium, making further extravasation 
more likely[120], because of  the cumulative and persistent 
effects related to their infusion[121] and, finally, because of  
safety concerns. Recent studies of  the potential increase 
in the risk of  bleeding and acute kidney injury following 
the application of  various colloids have shown that the 
use of  hydroxyethyl starch appears to be associated with 
an increased need for dialysis[122] and might even increase 
mortality in patients with sepsis[123].
Current evidence suggests that beyond fluid compo-
sition, the timing and volume of  the administered fluid 
represent two additional factors that are likely to influ-
ence perioperative patient outcome. For patients with 
mild-to-moderate volume deficits, crystalloids are still the 
first choice. In the case of  severe volume depletion, we 
recommend starting fluid resuscitation with a colloid to 
rapidly reverse volume deficits and ensure oxygenation 
and then to switch to crystalloids once the patient ap-
proaches euvolaemia. 
Goal-directed fluid management enables appropriate 
use of  fluids, vasopressors, and inotropes, and results in 
improved outcomes. The vasodilatatory effect of  anaes-
thetic cannot be ignored and must be expected to termi-
nate at the end of  surgery. Treating vasodilatation with 
crystalloids or colloids can be a mistake in all euvolaemic 
patient, whereas vasopressor infusion during surgical op-
eration can help in avoiding excessive fluid overload[124,125]. 
Optimisation of intraoperative ventilation
Postoperative pulmonary complications following major 
upper abdominal surgery increase morbidity, mortality, 
the length of  hospital stay and costs[33]. Reduced lung in-
flation represents one of  the basic mechanisms of  post-
operative pulmonary complications. The adjustment of  
the body positioning from upright to supine itself  can re-
duce the resting lung volume by approximately 0.8-1.0[126]. 
The additive effect of  supine positioning, general anaes-
thesia, and abdominal incisions significantly reduces func-
tional residual capacity and increases airway resistance. 
In addition, during the induction of  anaesthesia, most of  
the general anaesthetics further reduce functional residual 
capacity. The combination of  these effects predisposes 
patients to atelectasis with the risks of  hypoxemia and 
infection. Additionally, postoperative pain and the use of  
analgesics can contribute to a reduced tidal volume and 
impaired clearing of  secretions, depending on adequate 
coughing and deep breathing[126,127].
Mechanical ventilation is mandatory in patients un-
dergoing general anaesthesia. High tidal volumes can 
overdistend non-injured lungs, particularly in non-de-
pendent lung tissues. The non-aerated atelectatic lung re-
gions are prone to repeated collapse and re-expansion of  
the alveoli, causing shear stress and diffuse mechanical 
damage of  the alveoli. During surgical procedures, both 
phenomena can induce stress in non-injured lung tissues, 
triggering local inflammation[128,129]. Retrospective and 
prospective studies have shown the potential beneficial 
effects of  reduced tidal volumes in patients who are on 
short-term mechanical ventilation following surgery[130]. 
Protective mechanical ventilation using reduced tidal 
volumes can accordingly reduce ventilator-associated 
lung injury. The application of  positive end expiratory 
pressure (PEEP) can prevent alveolar collapse and atel-
ectasis formation, and recruitment manoeuvres can sup-
port the beneficial effects of  PEEP during short-term 
ventilation[131]. Effective anaesthesiological management 
during pancreatic surgery should involve the application 
of  a protective ventilation strategy (lower tidal volumes 
< 8 mL/kg, PEEP = 6-12 mmHg and recruitment ma-
noeuvres) to improve respiratory function during the 
postoperative period following abdominal surgery and to 
reduce the clinical signs of  pulmonary infection during 
the postoperative period[132].
Intraoperative thromboprophylaxis
The use of  LMWHs to prevent thrombotic events in 
these patients represents a common and well-document-
ed practice. Effective pharmacological thromboprophy-
laxis includes the administration of  LMWH from the day 
prior to the surgery. In addition to this useful approach 
mechanical prophylaxis including graduated compres-
sion stockings and intermittent pneumatic compression 
is highly recommended during the surgical operation and 
during the postoperative period until the risk of  bleeding 
has diminished and the application of  new pharmaco-
logical prophylaxis might be initiated[57,60].
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 Thromboelastography can play a potential role, de-
spite its limitations, as a valuable tool for the evaluation 
of  the entire perioperative coagulation process and hy-
percoagulability changes, as well as for increasing patient 
safety through more effective management of  antithrom-
botic therapy[133,134].
POSTOPERATIVE MANAGEMENT
Over the past 20 years, surgery and anaesthesia for pa-
tients undergoing abdominal surgery have undergone 
immense development. A novel concept of  periopera-
tive patient care following surgical abdominal procedures 
has emerged. Fast track programmes, a new concept of  
enhanced recovery after surgery and the implementation 
of  multimodal rehabilitation, have heavily influenced this 
modern change, optimising perioperative care, accelerat-
ing recovery and reducing hospital stays and costs. The 
objective of  this integrated approach between surgeon, 
anaesthetist, nurses and physiotherapist is to reduce the 
impact of  surgery on patient homeostasis. The main pil-
lars of  this new management are those shared by fast 
track surgery and can be summarised as follows: (1) re-
duction of  surgical invasiveness (early removal of  drains, 
nasogastric tube, small incisions, pharmacological stimu-
lation of  the gut); (2) pain relief/non-opioid oral anal-
gesia; (3) early oral nutrition/goal-directed fluid therapy; 
(4) intensive postoperative ambulation and prevention of  
venous thromboembolism; and (5) intensive respiratory 
rehabilitation. 
All of  these basic points, combined with the preven-
tion of  intraoperative hypothermia, neural blockades[135], 
maintenance of  euglycaemia, and the development of  
goal-directed fluid therapy contribute to the reduction of  
surgical stress.
A systematic review of  the literature regarding peri-
operative care in pancreatic cancer surgery has revealed 
a limited number of  studies providing low levels of  evi-
dence[50,54,136]. Despite their potential weaknesses, the stud-
ies detailed above have demonstrated that implementa-
tion of  fast-track peri-operative care pathways is feasible 
in pancreatic surgery and can be associated with reduced 
length of  stay, reduced relevant hospital costs and no in-
crease in morbidity, 30-d mortality or re-admission rates.
Early nasogastric tube, catheter and drain removal
Nasogastric tube: Nasogastric tubes have been rou-
tinely used following abdominal surgery until normal 
bowel function is restored, following the notion that gas-
tric decompression resulting from decreased air and fluid 
accumulation can prevent abdominal distension, nausea 
and vomiting. Many studies have subsequently ques-
tioned this practice, advising against its routine use. In 
fact, prophylactic nasogastric tube aspiration is associated 
with pulmonary complications[137] and significant patient 
discomfort. A recent study on the implementation of  
fast-track recovery pathways in pancreatic surgery[138] has 
underlined the advantages of  the early removal of  naso-
gastric tubes and early oral feeding in terms of  incidence 
of  delayed gastric emptying and earlier bowel activity. 
Given the risk of  pulmonary complications, significant 
patient discomfort and lack of  benefit associated with 
prophylactic nasogastric tube aspiration, this practice 
should not be routinely used[139,140].
Consistent with a recent study, in our daily practice, 
we remove nasogastric tubes on postoperative day 1 only 
if  the tube drainage amount is less than 300 mL or at the 
end of  surgery in cases of  distal pancreatectomy which 
makes delayed gastric emptying less frequent[52].
Abdominal drains: The presence of  an abdominal drain 
represents a significant impediment to achieving early and 
appropriate levels of  mobilisation. Several randomised 
trials have not found any benefit of  prophylactic drains 
after surgical operations, such as cholecystectomy[141], 
colorectal surgery[142] or hepatectomy[143]. Rather, these 
prospective randomised studies found that routine drain-
age resulted in an increased frequency of  complications 
and no difference in outcome.
Because pancreatic surgery is associated with high 
rates of  morbidity, the purpose of  prophylactic drainage 
is to prevent fluid collection and to aid in the early de-
tection of  anastomotic leak and associated haemorrhage. 
Following pancreatectomy, the use of  a prophylactic 
drain is supported by the belief  that the early detection 
of  pancreatic fistulae through the measurement of  amy-
lase in the draining fluid will allow for the efficient man-
agement and the avoidance of  major complications[144]. 
Despite reports of  randomised, control trials and cohort 
studies that do not support the use of  drains, most sur-
geons routinely place prophylactic intraperitoneal drains 
at the time of  pancreatic resections[145,146]. Evidence-
based practice guidelines for drain management during 
pancreatectomy remain to be established despite the 
remarkable number of  studies that are available to help 
guide practice.
At our University Hospital, abandoning drainage dur-
ing pancreatic surgery is believed to be unsafe, and ac-
cording to Kaminsky et al[146], it is reasonable to suggest 
a practice of  selective drainage based on the presence 
of  risk factors. The presence of  soft pancreas texture, a 
small pancreatic duct diameter, increased intraoperative 
blood loss (> 200 mL) and prolonged operative time 
are risk factors that reflect abdominal drains. In the case 
that patient is doing well and the drain amylase levels are 
below 5000 U/L, drains [on postoperative day 1 (POD 
1)] can be safely removed on POD 3 in patients with low 
risk of  pancreatic fistulae.
Early oral nutrition 
The restoration of  normal gastrointestinal function to al-
low adequate food intake and rapid recovery is one of  the 
primary objectives of  postoperative care. A meta-analysis 
of  controlled trials of  early enteral or oral versus ‘nil by 
mouth’ feeding after gastrointestinal surgery indicated no 
clear advantage to continued patient fasting after the elec-
tive gastrointestinal resection[147].
Concerning nutrition, studies have clearly found that 
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allowing eating/drinking until late the day prior to sur-
gery and commencement of  eating/drinking soon after 
surgery has many advantages[148,149]. Through the earlier 
intake of  fluids and solids, the gastrointestinal system is 
less affected with an earlier initiation of  normal intestinal 
activity.
An interesting review analysing which feeding routine 
was more favourable following pancreatoduodenectomy 
revealed no consensus in terms of  postoperative nutri-
tion of  patients who had undergone pancreatic surgery. 
Current European guidelines recommend routine en-
teral feeding after pancreatoduodenectomy, whereas the 
American guidelines do not. Gerritsen et al[150] concluded 
that there is no evidence to support routine enteral or 
parenteral feeding after pancreatoduodenectomy, whereas 
the oral diet appears to be the best feeding strategy.
At our University Hospital, it is common to allow 
the patient to take clear liquids from POD 1 but not be-
fore 6 h postoperatively and a light diet from POD 2, in 
the absence of  any complications. In patients at risk of  
postoperative complications such as pancreatic fistulae or 
abdominal collections, we advocate the use of  combined 
parenteral and enteral nutrition[52].
Total pancreatectomy and postoperative glycaemic 
control 
Total pancreatectomy, usually performed for the treat-
ment of  multifocal disease or in case of  atrophic, soft, 
friable remnant pancreatic tissue is responsible of  en-
docrine and exocrine insufficiency. In addition to the 
absence of  insulin, the endocrine abnormalities accom-
panying total pancreatectomy include both glucagon and 
pancreatic polypeptide deficiencies, which appears to 
play a key role in the increased hepatic insulin resistance 
observed in pancreatogenic diabetes[151]. Moreover, fol-
lowing pancreatectomy, insulin receptors are upregulated 
peripherally, rendering patients uniquely sensitive to hor-
mone replacement[152].
This type of  diabetic condition is defined “pancrea-
togenetic” diabetes and is often considered to be dif-
ferent from type 1 and 2 diabetes. This diabetic state is 
commonly described as “brittle”, as a result of  enhanced 
peripheral insulin sensitivity, decreased hepatic insulin 
sensitivity and reduction of  glucagon secretion. The 
resulting labile glycaemic control is characterized by peri-
odic episodes of  both hyper and hypoglycaemia[153,154]. 
In recent years, studies have shown that diabetes fol-
lowing total pancreatectomy is not necessarily associated 
with poor glycaemic control, and the majority of  cases 
exhibit equivalent biochemical controls compared to the 
normal type 1 diabetic population[155,156]. 
Recently, the development of  accurate, continuous 
blood glucose monitoring devices, particularly closed-
loop systems, for computer-assisted blood glucose con-
trol in the intensive care unit have been reported to assist 
in obtaining favourable glycaemic control in patients with 
pancreatogenic diabetes following pancreatic resection[157].
The hyperglycaemia induced by surgical stress can-
not be controlled using the conventional sliding scale 
method[158], whereas the perioperative use of  an artificial 
endocrine pancreas enables strict glycaemic control of  
euglycaemia without severe hypoglycaemia[159,160].
Modern pancreatic enzyme formulations have im-
proved exocrine insufficiency, facilitating glycaemic con-
trol due to the avoidance of  malabsorption[155]. 
The enhanced patient understanding of  the conse-
quences of  total pancreatectomy, early education on dia-
betes (all patients should consult an endocrinologist im-
mediately following their operation), advances in medical 
therapies, and blood glucose monitoring might all have 
contributed to enhanced glycaemic control[161]. 
Goal-directed fluid therapy
Early oral nutrition has to be associated to the individu-
alised postoperative fluid therapy that is administered in 
accordance to the optimisation of  stroke volume. Dy-
namic parameters such as stroke volume or pulse pres-
sure variation can provide a more favourable prediction 
of  fluid responsiveness. Oesophageal Doppler-guided 
fluid optimisation has been shown to improve patient 
outcomes, although this method cannot be performed 
on conscious patients[116,117]. Fluid challenges and the leg-
raising test can represent simple and valid alternatives[118]. 
Thus, oral nutrition has clearly be associated with a pro-
gressive decrease of  intravenous fluids.
Pain relief/non opioid oral analgesia
One aim of  fast track surgery is to obtain favourable pain 
control, which is intended to enable patient mobilisation, 
coughing and early nutrition. One of  the modern princi-
ples for analgesia is the concept of  opioid-sparing, which 
enhances recovery by avoiding the opioid-related side ef-
fects. In major abdominal procedures, the administration 
of  continuous thoracic epidural analgesia with local an-
aesthetics has been demonstrated to be the most efficient 
technique to obtain optimal analgesia, allowing for early 
mobilisation, reducing postoperative ileus and pulmonary 
morbidity[162], and therefore acting as an important com-
ponent of  multimodal recovery strategies[163,164]. A mid-
thoracic epidural activated prior to the initiation of  sur-
gery also blocks stress hormone release[165] and attenuates 
postoperative insulin resistance[166,167]. 
Fast-track clinical pathways in the peri-operative care 
of  patients undergoing pancreatic resection provide for 
a catheter placed in the midthoracic level at T8/9 to 
achieve both analgesic and sympathetic blocks[168].
Small doses of  epidural opioids have been shown 
to act in synergy with epidural local anaesthetics in 
providing analgesia, allowing reduced dosages of  both 
agents[169].
For break-through pain, non-steroidal anti-inflam-
matory drugs and bolus epidural bupivacaine should be 
administered whilst the epidural is running. Non-steroidal 
anti-inflammatory drugs should be administered just 
prior to the removal of  the epidural and continued until 
and/or after discharge.
As the optimal duration of  continuous postoperative 
mid-thoracic epidural analgesia has not been established 
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in well-designed randomised trials, we suggest that two-
to-three days might be a sufficient period for pancreatic 
surgery.
Patient-controlled analgesia using intravenous opioids 
does not provide the same efficient analgesia and elicits 
less beneficial physiological effects on surgical stress 
responses compared to local epidural anaesthetic tech-
niques. However, it is performed whenever contraindica-
tions prevent the execution of  peridural analgesia.
Intensive postoperative ambulation and prevention of 
venous thromboembolism
Among the standardised clinical pathways, which repre-
sent the basis of  the fast-track programme, early mobili-
sation is a cornerstone. It has been shown to play a major 
role in postoperative functional recovery. Improved early 
ambulation can elicit beneficial effects in the resolution 
of  postoperative ileus and can reduce the risk of  lower 
extremity deep venous thrombosis. Furthermore, mobili-
sation might reduce pulmonary complications[170]. The 
risk for VTE, which is particularly high in this patient 
population, must be managed from the beginning of  the 
preoperative period and continue during the entire surgi-
cal operation until the postoperative period as a result of  
early mobilisation and proper pharmacological throm-
boprophylaxis. At our University Hospital, we generally 
mobilise patients out of  their beds for more than one 
hour from POD 1 and progressively increase the hours 
of  mobilisation from POD 2. Patients who had under-
gone major abdominal surgery for gastrointestinal ma-
lignancies should be considered for post-discharge VTE 
prophylaxis for up to 4 wk following surgery during the 
following situations: residual or metastatic disease, obe-
sity or previous history of  VTE.
Intensive respiratory rehabilitation
Pulmonary complications following pancreatic resection 
occur in approximately one quarter of  all patients[171]. 
Many pathophysiological modifications that occur under 
anaesthesia and/or following surgery can interact with 
each other, resulting in respiratory complications.
Reduced lung inflation is one of  the basic causes of  
postoperative pulmonary dysfunction[172].
After upper abdominal and thoracic surgery, postop-
erative diaphragmatic dysfunction[173], which is the most 
important determinant of  respiratory complications and 
atelectasis, is commonly observed and is caused by the 
mechanical compression of  alveoli and the resorption of  
alveolar gases, which are the factors most commonly im-
plicated in respiratory complications[174].
In recent years, breathing (deep breathing and di-
rected cough) and chest wall physiotherapy have been 
introduced into clinical practice to prevent pulmonary 
complications. Physiotherapy includes a variety of  man-
ual treatments (postural drainage, percussion, clapping, 
vibration, or shaking) as well as the use of  mechanical 
breathing devices (incentive spirometry, blow bottles, 
intermittent positive pressure breathing, and continuous 
positive airway pressure).
A systematic review showed that postoperative non-
invasive ventilation, specifically continuous positive air-
way pressure (CPAP), improves hypoxaemia and reduces 
both postoperative complications and the requirement 
for intubation in patients undergoing abdominal sur-
gery[170]. Furthermore, there is no specific study focusing 
on the role of  chest physiotherapy after pancreatic re-
section; it is nonetheless included in the care plan at our 
institution. Every patient who has undergone pancreatic 
surgery is instructed to use a blow bottle (5 min/h) and 
undergoes an individualised exercise schedule that is de-
signed by physiotherapists. Further, certain short courses 
of  non-invasive mechanical ventilation (CPAP) can be 
performed as needed.
Intensive postoperative management
Despite continuous improvements in operative tech-
nique and perioperative management, the increasing age 
of  patients undergoing major abdominal surgery ex-
poses patients to an increasing number of  postoperative 
complications, leading to increased morbidity, mortality, 
length of  hospital stay, and hospital costs. Although the 
concept of  fast-track surgery has questioned the tra-
ditional use of  intensive care units, there is increasing 
evidence indicating that access to ICUs results in a more 
favourable impact on the outcomes of  major abdominal 
surgeries.
In the case of  pancreaticoduodenectomy, even high-
volume centres report a major postoperative complica-
tion rate of  approximately 20%[175]. Because of  these 
observations, patients who undergo pancreatic cancer 
surgeries might benefit from admission to the ICU.
An ideal ICU model should involve the cooperation 
of  the intensivists who primarily care for the patients 
with the primary physician and surgeon[176].
Current general concepts of  fast track surgery have 
been implemented in intensive care units. Early mobilisa-
tion, early enteral feeding, and restrictive perioperative 
fluid management are generally performed at the ICUs 
of  our institution. In addition to these programmes, ICU 
stays can offer extended haemodynamic monitoring, 
which is useful in goal-directed fluid therapy, the possibil-
ity of  invasive and non-invasive ventilation, the continu-
ous application of  intravenous drugs or subsequently 
required extracorporeal procedures.
In summary, most patients who undergo elective 
pancreatic surgery for cancer do not necessary require 
intensive care admission, whereas high-risk patients 
might benefit from postoperative care in the ICUs. We 
suggest that surgical intensive care units play a pivotal 
role in the perioperative care of  patients undergoing ma-
jor abdominal surgeries, and patients with co-morbidities 
or elderly patients should be scheduled for intensive care 
treatment[177,178]. 
CONCLUSION
In recent decades, diagnostic modalities and the surgi-
cal treatments of  PC have significantly progressed, de-
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spite the fact that overall prognosis has only marginally 
changed. The management of  patients affected by PC is 
complex and requires expertise in many fields. Multidisci-
plinary teams are necessary to optimise and improve the 
overall care and outcomes of  patients. Because more pa-
tients are referred to surgery at an advanced age, a coor-
dinated effort between surgeon and anaesthetist in terms 
of  risk assessment is necessary, particularly for borderline 
resectable or unresectable disease cases (to spare the 
risk and cost of  surgery for patients who are affected by 
advance disease and whose life expectancy might be po-
tentially shortened by an unuseful and dangerous surgical 
operation)[179]. More favourable outcomes are attained if  
PC patients are appropriately referred to tertiary centres 
for assessment by surgical, medical and radiation oncolo-
gists, gastroenterologists, anaesthetists and other dedi-
cated health care providers. The anaesthetist plays a key 
role in the preoperative assessment, intraoperative man-
agement and during the postoperative period assessment. 
For this reason, close cooperation between surgeons and 
anaesthesiologists is crucial for ensuring the safe perfor-
mance of  major gastrointestinal surgery with acceptable 
morbidity and mortality rates.
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